Skip to content

XIENCE V 1009542-15Recalls & reported problems

Abbott Vascular Inc. · XIENCE V Everolimus Eluting Coronary Stent System 3.50 mm x 15 mm / Rapid-Exchange · Class 3 · Implant

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 08717648064258), received between Dec 6, 2016 and Dec 6, 2016 — classified as 1 injury.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1

Patient problems

  • Angina1
  • Stenosis1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryDec 6, 2016Adverse Event Without Identified Device or Use Problem

    (B)(6). IT WAS REPORTED THAT ON (B)(6) 2013, THREE XIENCE V STENTS (TWO 3.5X15S AND ONE 3.0X12) WERE IMPLANTED IN THE DISTAL LEFT MAIN TO THE PROXIMAL LEFT ANTERIOR DESCENDING CORONARY ARTERY (PLAD) AND THE LEFT MAIN TO THE LEFT CIRCUMFLEX CORONARY ARTERY. THE PATIENT HAD CHEST PAIN ON (B)(6) 2016. RESTENOSIS WAS FOUND IN ONLY ONE STENT IN THE PLAD TARGET LESION TREATED WITH PERCUTANEOUS CORONARY INTERVENTION. THE CONDITION RESOLVED. NO ADDITIONAL INFORMATION WAS PROVIDED.

    Patient problems: Angina; Stenosis

    MAUDE report 6148288 ↗

Other Coronary drug-eluting stent devices

All Coronary drug-eluting stent devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page